Skip to content
DeepViews

Ainos, Inc. Common Stock (AIMD) — Analysis Summary

Ainos, Inc. Common Stock (AIMD) has a market cap of $8.42M with year-over-year revenue growth of +499.0%. Net margin stands at -11897.0%. The stock trades at a P/E ratio of -0.6.

Key Takeaways

  • Revenue changed +499.0% year-over-year
  • Net margin of -11897.0%
  • P/E ratio of -0.6

Compared to other companies in the COMPUTER PERIPHERAL EQUIPMENT, NEC sector, AIMD posted revenue growth of +499.0% and trades at a P/E of -0.6.

[XNAS]

Ainos, Inc. Common Stock (AIMD)

$1.14

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$8.42M
Enterprise Value
$17.99M
P/E Ratio
-0.6
Div Yield
0.00%
EV/EBITDA
-2.0
Company Profile
About
About Ainos, Inc. Common Stock

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Sector

COMPUTER PERIPHERAL EQUIPMENT, NEC

Employees

41

Headquarters

HOUSTON, TX

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
33
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$3.28M
Total Debt$11.00M
Debt-to-Equity3.35
Cash & Equivalents$1.42M

Cash Flow

Operating Cash Flow$-4.47M
Free Cash Flow$-4.49M
FCF Margin-33046.94%
P/FCF Ratio-1.87
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.